Collecting health data and samples from patients with brain cancer and neurological disorders
Study of Clinical Biomarkers in Human Health and Disease (Healthiomics)
CureScience · NCT05106725
This study is collecting health information and samples from patients with brain cancer and neurological disorders to help find better treatments and improve care for them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | CureScience (other) |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (San Diego, California) |
| Trial ID | NCT05106725 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather clinical data, biological specimens, and digital health information from patients with brain cancer and neurological disorders. By creating a biorepository, the study will facilitate research into predictive biomarkers and personalized treatments that could enhance patient care. It will also provide a historical dataset for comparing new treatments against standard therapies for brain tumors. The focus is on developing prognostic models that guide treatment decisions and improve patient outcomes.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with brain cancer, neurological disorders, or those undergoing evaluation for these conditions.
Not a fit: Patients without any neurological complications or cancer, who do not meet the inclusion criteria, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective treatments for patients with brain cancer and neurological disorders.
How similar studies have performed: Other studies have shown success in using similar approaches to identify biomarkers and improve treatment strategies, indicating a promising avenue for this research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participant or participant's legally authorized representative has the ability to understand and the willingness to provide a signed and dated informed consent form. * Participant is ≥ 18 years of age. * Participant had/has a scheduled appointment with oncology or neurosciences services at the participating medical and surgical facility. * Participant is characterized by at least one of the following criteria: 1. Has a neurological complication from any type of cancer, or is under evaluation for a possible cancer diagnosis or neurologic complication. Participant may be newly diagnosed, in relapse, or be free of disease at the time of recruitment. Participant without a confirmed cancer diagnosis is eligible.; OR 2. Has a neurological disorder, or is under evaluation for a possible diagnosis of a neurological disorder; OR 3. Does not meet the characteristic of either a. or b. above. This participant would be considered a "healthy control" for cancer and neurological disorders. Exclusion Criteria: * Participant or participant's legally authorized representative is unable to provide informed consent.
Where this trial is running
San Diego, California
- CureScience Institute — San Diego, California, United States (RECRUITING)
Study contacts
- Principal investigator: Feng Lin, MD PhD — CureScience
- Study coordinator: Amanda Wilburn
- Email: awilburn@curescience.orgg
- Phone: 8588002873
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Brain Cancer, Neurological Disorder, Neurological Cancer, wearables, digital health, biospecimens